Differential protein expression profile in gastrointestinal stromal tumors
β Scribed by B. Landuyt; H. Prenen; M. Debiec-Rychter; R. Sciot; E. A de Bruijn; A. T. van Oosterom
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 113 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0939-4451
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Telomerase activity has been observed in 80 -90% of carcinomas derived from various organs. However, to the authors' knowledge this report is the first assessment of telomerase activity in gastrointestinal stromal tumors (GISTs). ## METHODS. Telomerase activity was analyzed by th
## Abstract MicroRNAs are known to regulate gene expression. Although unique microRNA expression profiles have been reported in several tumors, little is known about microRNA expression profiles in GISTs. To evaluate the relationship between microRNA expression and clinicopathologic findings of GIS
## Abstract Imatinib is standard firstβline treatment for patients with advanced gastrointestinal stromal tumor (GIST). Initial responses are not always accompanied by reductions in tumor size; consequently, other parameters should be considered in response assessments. Conventional sizeβbased crit